Thrombotic thrombocytopenic purpura and severe preeclampsia: a clinical overlap during pregnancy and a possible coexistence.
HELLP syndrome
Preeclampsia
Thrombotic thrompocytopenic purpura
sFlt1-PlGF ratio
Journal
Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
05
11
2021
revised:
26
05
2022
accepted:
06
06
2022
pubmed:
11
6
2022
medline:
31
8
2022
entrez:
10
6
2022
Statut:
ppublish
Résumé
In pregnant women, Thrombotic Thrombocytopenic Purpura (TTP) mimics severe preeclampsia because of the overlapping of these symptoms. We report the case of a 28-years-old woman who presented severe thrombocytopenia (platelets at 34 G/L) at 31 gestational weeks. The day after, she showed anaemia, worsening thrombocytopenia (platelets at 6 G/L) and an isolated increase of AST (91 UI/L). Plasmapheresis was performed without improvement. Secondary, she presented hypertension and proteinuria at 15 g/24 hours and elevated liver enzymes (AST 116 UI/L). A cesarean section was performed on day four for suspected HELLP syndrome. We observed in postpartum a progressive increase of platelets and regression of hepatic cytolysis. The sFlt1/PlGF ratio was elevated at 855, the results of ADAMTS13 activity were below 5 %, and the ADAMTS13 gene was mutated. TTP and HELLP syndrome can co-exist and can complicate one another. TTP lead to placental malperfusion. Further studies are needed to confirm the diagnosis value of the sFlt-1/PlGF ratio in TTP pregnant women.
Identifiants
pubmed: 35688323
pii: S2468-7847(22)00105-2
doi: 10.1016/j.jogoh.2022.102422
pii:
doi:
Substances chimiques
FLT1 protein, human
EC 2.7.10.1
Vascular Endothelial Growth Factor Receptor-1
EC 2.7.10.1
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
102422Informations de copyright
Copyright © 2022 Elsevier Masson SAS. All rights reserved.